18-50921113-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002396.5(ME2):c.982G>T(p.Val328Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000625 in 1,600,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002396.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ME2 | NM_002396.5 | c.982G>T | p.Val328Leu | missense_variant | 10/16 | ENST00000321341.11 | |
ME2 | NM_001168335.2 | c.982G>T | p.Val328Leu | missense_variant | 10/14 | ||
ME2 | NR_174094.1 | n.1185G>T | non_coding_transcript_exon_variant | 10/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ME2 | ENST00000321341.11 | c.982G>T | p.Val328Leu | missense_variant | 10/16 | 1 | NM_002396.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 240292Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 130036
GnomAD4 exome AF: 0.00000414 AC: 6AN: 1448466Hom.: 0 Cov.: 28 AF XY: 0.00000555 AC XY: 4AN XY: 720542
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2023 | The c.982G>T (p.V328L) alteration is located in exon 10 (coding exon 9) of the ME2 gene. This alteration results from a G to T substitution at nucleotide position 982, causing the valine (V) at amino acid position 328 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at